Online ECHO Clinic | June 1, 2020
Presentation Titles: COVID-19 Epi Updates: Testing Considerations | CDC, FDA Research & Resources | COVID-19 Update
In this series of three presentations, Dr. Thomas Weiser provides an epidemiological update on COVID-19, focusing on testing recommendations and considerations. Then, Celeste Davis, shares valuable resources from the FDA and CDC. Finally, Dr. Jorge Mera, Director of Infectious Diseases for Cherokee Nation Health Services, shares clinical updates on COVID-19.
Thomas Weiser, MD, MPH, has been with Portland Area Indian Health Services since 1998, initially serving as an Indian Health Services Medical Officer in Whiteriver, Arizona from 1998-2005. He completed the CDC Epidemiology Intelligence Service from 2005-2007, assigned to the Missouri Department of Health and Senior Services. In 2007, he began his new position assigned to the Northwest Portland Area Indian Health Board and Northwest Tribal Epidemiology Center. Dr. Weiser is passionate about improving the quality of healthcare services, data access and data quality for American Indian and Alaska Native populations; human subjects protection; infectious disease epidemiology and surveillance.
Celeste Davis, MPH, REHS, is a citizen of the Chickasaw Nation of Oklahoma. She is a Registered Environmental Health Specialist who earned a Bachelor of Science degree in Environmental Health Science from East Central University in Ada, Oklahoma, and a Master of Public Health degree in Occupational and Environmental Health from the University of Oklahoma.
Jorge Mera, MD, FACP, is the Director of Infectious Diseases for Cherokee Nation Health Service, the largest tribally operated health care system in the United States. He oversees surveillance, policies, and programs to treat and prevent the transmission of sexually transmitted diseases, HIV and HCV.
SARS-CoV-2 Infection Protects Against Rechallenge in Rhesus Macaques (Science Magazine)
The UW MetaCenter (UW)
COVID-19 Literature Situation Report (WA DOH, UW)